证券出售报告
Gyre Therapeutics(GYRE)07-19 04:35
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005523 Act: 33 Size: 10 KB 网页链接
简介:北京康蒂尼药业股份有限公司创立于2002年,是一家以器官纤维化疾病为核心,集研发、生产、销售于一体的创新药物开发企业。 作为器官纤维化领域的先行者,公司的旗舰产品1.1类新药艾思瑞(呲非尼酮胶囊)是全球唯二已获批且受指南推荐的特发性肺纤维化(IPF)治疗药物,也是国内首款用于治疗IPF的创新药物,2014年成功上市后填补了该领域的空白。公司下一阶段关键性产品一治疗肝纤维化的F351(轻尼酮)被药审中心认定为“突破性治疗药物”有望成为全球首款获批治疗慢性乙肝(CHB)相关纤维化的药物。 公司将通过艾思瑞积累的从自主开发到商业化成功的完整经验丰富并推进产品管线,将治疗领域逐渐拓宽至其他器官纤维化,研究和开发治疗肺纤维化、肝纤维化及肾纤维化的创新药品,为更多器官纤维化患者带来新希望。
今开:15.06 | 昨收:14.98 |
最高:15.12 | 最低:14.81 |
涨停价: | 跌停价: |
总市值:1284361942 |
Gyre Therapeutics(GYRE)07-19 04:35
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005523 Act: 33 Size: 10 KB 网页链接
Gyre Therapeutics(GYRE)07-18 04:35
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005496 Act: 33 Size: 10 KB 网页链接
Gyre Therapeutics(GYRE)07-17 04:05
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005430 Act: 33 Size: 9 KB 网页链接
Gyre Therapeutics(GYRE)07-16 05:25
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005428 Act: 33 Size: 8 KB 网页链接
Gyre Therapeutics(GYRE)07-13 04:45
$Gyre Therapeutics(GYRE)$ RW Registration Withdrawal Request Accession Number: 0001140361-24-033067 Act: NE Size: 64 KB 网页链接
Gyre Therapeutics(GYRE)07-13 04:45
$Gyre Therapeutics(GYRE)$ RW Registration Withdrawal Request Accession Number: 0001140361-24-033066 Act: NE Size: 64 KB 网页链接
Gyre Therapeutics(GYRE)07-06 04:55
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 3.01 and 5.02 Accession Number: 0001140361-24-032511 Act: 34 Size: 167 KB 网页链接
Gyre Therapeutics(GYRE)07-04 01:25
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005238 Act: 33 Size: 7 KB 网页链接
Gyre Therapeutics(GYRE)07-03 05:15
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005217 Act: 33 Size: 7 KB 网页链接
Gyre Therapeutics(GYRE)07-02 06:05
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005185 Act: 33 Size: 6 KB 网页链接
SeekingBiotech05-23 14:06
F230片 北京康蒂尼药业股份有限公司 肺动脉高压查看全文
股市闲谈03-15 15:11
康蒂尼药业去年借壳上市之后一直没怎么发声,今年应该会有比较大的动作查看全文
Gyre Therapeutics(GYRE)02-15 06:25
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001140361-24-008051 Act: 34 Size: 1 MB 网页链接查看全文
Gyre Therapeutics(GYRE)02-15 02:25
$Gyre Therapeutics(GYRE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000173 Act: 34 Size: 30 KB 网页链接查看全文
Gyre Therapeutics(GYRE)01-25 06:15
$Gyre Therapeutics(GYRE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-003688 Act: 34 Size: 76 KB 网页链接查看全文
Gyre Therapeutics(GYRE)01-20 05:15
$Gyre Therapeutics(GYRE)$ 8-K/A [Amend] Current report, items 3.01, 5.02, and 9.01 Accession Number: 0001140361-24-002903 Act: 34 Size: 303 KB 网页链接查看全文
Gyre Therapeutics(GYRE)01-13 05:05
$Gyre Therapeutics(GYRE)$ 8-K/A [Amend] Current report, items 2.01 and 9.01 Accession Number: 0001140361-24-002118 Act: 34 Size: 2 MB 网页链接查看全文
Gyre Therapeutics(GYRE)2023-12-16 05:25
$Gyre Therapeutics(GYRE)$ 8-K Current report, item 5.02 Accession Number: 0001140361-23-057889 Act: 34 Size: 166 KB 网页链接查看全文
Gyre Therapeutics(GYRE)2023-12-07 05:05
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001140361-23-056503 Act: 34 Size: 220 KB 网页链接查看全文
Gyre Therapeutics(GYRE)2023-11-30 05:05
$Gyre Therapeutics(GYRE)$ RW Registration Withdrawal Request Accession Number: 0001140361-23-055209 Act: NE Size: 24 KB 网页链接查看全文
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005523 Act: 33 Size: 10 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005496 Act: 33 Size: 10 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005430 Act: 33 Size: 9 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005428 Act: 33 Size: 8 KB 网页链接
$Gyre Therapeutics(GYRE)$ RW Registration Withdrawal Request Accession Number: 0001140361-24-033067 Act: NE Size: 64 KB 网页链接
$Gyre Therapeutics(GYRE)$ RW Registration Withdrawal Request Accession Number: 0001140361-24-033066 Act: NE Size: 64 KB 网页链接
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 3.01 and 5.02 Accession Number: 0001140361-24-032511 Act: 34 Size: 167 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005238 Act: 33 Size: 7 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005217 Act: 33 Size: 7 KB 网页链接
$Gyre Therapeutics(GYRE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005185 Act: 33 Size: 6 KB 网页链接